Associated Papers
Predisposition to hematopoietic malignancies by deleterious germline CHEK2 variants.
Stubbins RJ et al.
Leukemia, 2025
40335619 (PubMed )
Supplement: 41375_2025_2635_MOESM5_ESM.xls › CHEK2_Supplemental_Table_4_v25
Classification of Gene Variants in a Danish Population with Suspected Predisposition to Hereditary Breast and/or Ovarian Cancer.
Munch AK et al.
Cancers, 2025
40507299 (PubMed )
Supplement: cancers-17-01819-s001.zip › cancers-3594035-supplementary.pdf
Systematic Minigene-Based Splicing Analysis and Tentative Clinical Classification of 52 CHEK2 Splice-Site Variants.
Sanoguera-Miralles L et al.
Clinical Chemistry, 2024
Clinical Application of Multigene Panels: Challenges of Next-Generation Counseling and Cancer Risk Management.
Slavin TP et al.
Frontiers in Oncology, 2015
A putative "hepitype" in the ATM gene associated with chronic lymphocytic leukemia risk.
Martín-Guerrero I et al.
Genes, Chromosomes & Cancer, 2011
The spectrum of ATM missense variants and their contribution to contralateral breast cancer.
Broeks A et al.
Breast Cancer Research and Treatment, 2008
Breast cancer genetics: unsolved questions and open perspectives in an expanding clinical practice.
Hodgson SV et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics, 2004
Select a paper to view details